02Aug
FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues
Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...
By:
Wilson Sonsini Goodrich & Rosati
Related
Q: I heard New York is changing its rules around tip credits for some types of employees. What do ...
Read More >
The strong pace of craft brewery acquisitions seen in recent years will likely reverse course in 202...
Read More >
In Florida, when the injured employee’s attorney files a verified motion for attorney’s fees and c...
Read More >
Company Fired Employees for Reporting and/or Verifying Sexual Harassment, Federal Agency Charged - ...
Read More >
The impact of COVID-19 on construction and development is evolving each and every day. Issues have a...
Read More >
For contractors and subcontractors, late payments can be an all-too-familiar part of the constructio...
Read More >